At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Juan Ignacio Aróstegui Gorospe, MD, PhD, from the Hospital Clínic de Barcelona, Barcelona, Spain, talks about the pathophysiology and treatment of the condition hyperimmunoglobulinaemia D with periodic fever syndrome (HIDS).
Pathophysiology and treatment of hyperimmunoglobulinaemia D with periodic fever syndrome (HIDS)
		19 Apr 2016
		
		
	
	
	
		
			
	
				
				Rheumatology
			
		
	
		
		
		
			Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.





